Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma

Summary

Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma is a master's thesis^[1].

Key Facts

• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma authored Zhe Fu^[2].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's instance of is recorded as master's thesis^[3].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's publisher is recorded as ResearchSpace@Auckland^[4].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's country of origin is recorded as New Zealand^[5].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's publication date is recorded as +2015-00-00T00:00:00Z^[6].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's main subject is recorded as biomedical sciences^[7].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's Handle ID is recorded as 2292/27118^[8].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's title is recorded as Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma^[9].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's copyright holder is recorded as Zhe Fu^[10].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's thesis submitted to is recorded as University of Auckland^[11].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's on focus list of Wikimedia project is recorded as NZThesisProject^[12].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's copyright status is recorded as copyrighted^[13].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's online access status is recorded as closed user group^[14].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's thesis committee member is recorded as Chris P. Guise^[15].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's thesis committee member is recorded as Adam Patterson^[16].
• Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's thesis committee member is recorded as Jeff Smaill^[17].

Body

Designation and Status

Development of pre-clinical models to evaluate novel aldo-keto reductase 1C3 prodrugs for treatment of hepatocellular carcinoma's instance of is recorded as master's thesis^[3].